Christoph Daniel Selected Research

Hemoglobins (Hemoglobin)

1/2022	Divergent roles of haptoglobin and hemopexin deficiency for disease progression of Shiga-toxin-induced hemolytic-uremic syndrome in mice.
1/2018	Modeling Hemolytic-Uremic Syndrome: In-Depth Characterization of Distinct Murine Models Reflecting Different Features of Human Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Daniel Research Topics

Disease

18	Proteinuria 01/2022 - 11/2002
18	Inflammation (Inflammations) 01/2022 - 03/2007
18	Glomerulonephritis 12/2018 - 11/2002
14	Nephritis 01/2021 - 04/2005
13	Fibrosis (Cirrhosis) 01/2021 - 09/2003
8	Hypertension (High Blood Pressure) 01/2021 - 08/2011
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 12/2007
5	Thrombotic Microangiopathies 01/2022 - 10/2006
5	Infections 01/2022 - 11/2015
5	Renal Insufficiency (Renal Failure) 01/2021 - 02/2007
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2007
4	Body Weight (Weight, Body) 01/2021 - 01/2006
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2021 - 01/2008
4	Kidney Diseases (Kidney Disease) 05/2020 - 09/2003
4	Albuminuria 01/2017 - 05/2012
3	Hemolytic-Uremic Syndrome 01/2022 - 01/2018
3	COVID-19 01/2022 - 01/2020
3	Disease Progression 01/2022 - 01/2021
3	Reperfusion Injury 01/2021 - 01/2009
3	Autoimmune Diseases (Autoimmune Disease) 07/2019 - 07/2015
3	Hypoxia (Hypoxemia) 01/2019 - 03/2008
3	Lupus Nephritis 01/2018 - 01/2012
3	Atherosclerosis 02/2016 - 12/2014
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 06/2013
2	Hemolysis 01/2022 - 01/2018
2	Microvascular Rarefaction 03/2021 - 01/2013
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 01/2021 - 01/2018
2	Weight Loss (Weight Reduction) 01/2021 - 01/2018
2	Delayed Graft Function 01/2021 - 01/2018
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 01/2018
2	Shock 12/2020 - 01/2013
2	Neoplasms (Cancer) 12/2020 - 12/2018
2	Ischemia 01/2020 - 04/2017
2	Arthritis (Polyarthritis) 07/2019 - 01/2019
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2019 - 01/2016
2	Myocardial Infarction 01/2019 - 12/2014
2	Cysts 12/2018 - 07/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2018 - 01/2016
2	Vascular Calcification 01/2018 - 03/2017
2	Cakut 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

10	Complement System Proteins (Complement)IBA 01/2022 - 06/2013
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2007
8	CytokinesIBA 01/2019 - 09/2003
7	CreatinineIBA 01/2018 - 11/2002
7	Transforming Growth Factor beta (TGF-beta)IBA 11/2009 - 09/2003
6	AutoantibodiesIBA 11/2021 - 06/2013
5	EnzymesIBA 11/2020 - 06/2013
4	SodiumIBA 01/2022 - 01/2013
4	Peptides (Polypeptides)IBA 09/2021 - 02/2004
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2008
4	antiglomerular basement membrane antibodyIBA 01/2021 - 01/2013
4	CollagenIBA 01/2020 - 01/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 10/2006
4	Immunoglobulin A (IgA)IBA 12/2018 - 06/2012
4	Urea (Carbamide)FDA LinkGeneric 01/2018 - 11/2002
4	Thrombospondin 1IBA 01/2009 - 12/2007
3	LectinsIBA 01/2022 - 01/2013
3	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 01/2020
3	SaltsIBA 01/2021 - 01/2018
3	Immunoglobulin G (IgG)IBA 12/2018 - 01/2013
3	Messenger RNA (mRNA)IBA 01/2017 - 05/2009
3	GTP-Binding Proteins (G-Protein)IBA 11/2016 - 12/2014
3	Estrogen ReceptorsIBA 11/2016 - 12/2014
3	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2016 - 04/2014
3	Everolimus FDA Link 01/2008 - 10/2006
2	Shiga Toxin (Shigella Toxin)IBA 01/2022 - 01/2018
2	Aprotinin (Trasylol)FDA Link 01/2022 - 01/2018
2	serum P-component (CIt)IBA 01/2022 - 01/2021
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 12/2021 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2021 - 04/2017
2	AntigensIBA 11/2021 - 05/2013
2	VaccinesIBA 11/2021 - 12/2019
2	Apolipoproteins E (ApoE)IBA 09/2021 - 02/2016
2	Serine Proteases (Serine Protease)IBA 01/2021 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 11/2015
2	Epithelial Sodium ChannelsIBA 01/2021 - 01/2018
2	PlasminogenIBA 01/2021 - 08/2011
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2020 - 01/2013
2	ImmunosorbentsIBA 07/2019 - 06/2013
2	Antigen-Antibody Complex (Immune Complex)IBA 07/2019 - 12/2018
2	Receptor for Advanced Glycation End ProductsIBA 07/2019 - 07/2014
2	pristane (pristan)IBA 07/2019 - 06/2013
2	AutoantigensIBA 07/2019 - 06/2013
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 08/2011
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2019 - 10/2013
2	Extracellular Matrix ProteinsIBA 01/2019 - 05/2009
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2018 - 01/2013
2	Fibrinolysin FDA Link 01/2018 - 08/2011
2	IntegrinsIBA 01/2018 - 05/2012
2	Mitogen-Activated Protein KinasesIBA 12/2017 - 01/2013
2	Coloring Agents (Dyes)IBA 03/2017 - 01/2017
2	Periodic AcidIBA 01/2017 - 05/2009
2	Protein Isoforms (Isoforms)IBA 11/2016 - 01/2013
2	Angiotensin IIIBA 11/2016 - 08/2011

Therapy/Procedure

12	Therapeutics 01/2022 - 09/2003
4	Kidney Transplantation 01/2021 - 01/2017
4	Intravenous Injections 01/2020 - 01/2006
3	Nephrectomy 01/2021 - 01/2013
2	Transplantation 03/2021 - 01/2021